1. Scrip
  2. >>Therapy Areas

The Eyes Have It For Shire With Lifitegrast Filing In Europe

 
• By Kevin Grogan

The drug, marketed across the Atlantic as Xiidra, has already made significant inroads in the US dry eye market which has been dominated by Allergan's Restasis

Market share
Shire is after a bigger slice of the dry eye market • Source: Shutterstock

Shire's bid to further boost its presence in the dry eye disease market has been boosted by the submission of lifitegrast in Europe.

The company says that the marketing authorization application for lifitegrast, submitted last week, has been validated by the UK as...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Sensory

More from Therapy Areas